Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tessa Therapeutics

Request full access

Clinical-stage biotechnology company focused on the development

Singapore, SingaporeFounded 2001Biotech & Life Sciences

About Tessa Therapeutics

Tessa Therapeutics is a biopharmaceutical company that specializes in the development and commercialization of cell therapies for cancer treatment. The company operates in the healthcare sector, specifically in the field of oncology. It serves a broad range of clients, including hospitals, healthcare providers, and patients suffering from various types of cancer.

Tessa Therapeutics' business model revolves around the research, development, and commercialization of innovative cell therapies. The company's primary source of revenue comes from the sale of these therapies to healthcare providers. It also generates income from partnerships with other pharmaceutical and biotech companies, where it licenses its technology or collaborates on joint research projects.

The company's flagship product is a type of cell therapy known as Virus-Specific T cells (VSTs). These are a new class of drugs that use the body's own immune system to fight cancer. The therapy involves extracting T cells (a type of white blood cell) from a patient, modifying them in a lab to target specific viruses associated with cancer, and then reintroducing them into the patient's body. This approach has shown promise in treating a variety of cancers, including nasopharyngeal carcinoma (a type of head and neck cancer), and cervical cancer.

In summary, Tessa Therapeutics is a biopharmaceutical company that operates in the oncology market. It generates revenue through the sale of its innovative cell therapies and through partnerships with other companies in the healthcare sector.

Source: Dealroom company data

At a glance

Status
Operational
Employees
33
Open positions
None listed
Dealroom signal
64.5/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Oncology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANTOther financing May 2023 $100K — Undisclosed ↗
SERIES AOther financing Jun 2022 $126M $504M EDBI · Temasek · Heritas Capital Management · Polaris Partners ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Tessa Therapeutics website traffic

Latest recorded traffic for Tessa Therapeutics is 1K monthly website visits, down 16.7% over the last three months. Tessa Therapeutics's team declined 10.8% over the past year.

Latest monthly visits1K 3-month web change-16.7% 1-year team growth-10.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Tessa Therapeutics in the Singapore ecosystem

Live from Dealroom

The Tessa Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Series B and later3 investors entered at this stage

  • EDBI
  • Temasek
  • Heliconia Capital Management

Other known investors1 additional known investor

  • Baylor College of Medicine
Team profiled 17 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇸🇬 Singapore86.7%
🇺🇸 United States6.7%
🇦🇿 Azerbaijan6.7%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tessa Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tessa Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.